chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was fine during the 15 minute observation period. On the drive , approximately 30 minutes after injection I had to clear my throat frequently. This lasted about 2 hours. I did not have any noticeable swelling of my mouth or airway. I was able to breathe fine and did not feel short of breath.  The need to clear my throat eased after a couple of hours and was gone by 5 or 6 hours post injection. At home about an hour after the injection I also noted to my right cheek some pinkness/redness and swelling. It appeared like a possible hive. There was no scratchiness. The redness eased over 12-24 hours, but it was still marginally discolored. The swelling lasted several days and is still present to a lesser degree. I had the expected symptoms of sore arm, fatigue and mild fever (up to 100.9) - none of which were concerning, but the need to clear my throat and the hive were unexpected and thus the reason for the report.
The night of the shot I began feeling nauseous about 11:30 pm.  Started (violently) vomiting & had Diarrhea non stop from 2 am  till approx 9:30 am that next morning of Jan 30th.  Vomiting was coming about every 10-15 minutes & lasted 4-5 minutes even when it became dry-heaves.  Diarrhea never stopped, i had no control over it at all.   Today is Feb 7th & I still have no appetite, just eating crackers a little cheese & I have tried plain grilled chicken.  I have kept it down but feel nauseous when I do try to eat.
Information has been received from a nurse concerning a 20 year old female with no routine medications and slight allergy to dust otherwise no know allergies who on 12-MAR-1996 was vaccinated with the first dose of VARIVAX (Merck) (Lot# 608586/0413B, therapy dose, route and site unknown) and on 18-OCT-2007 received the second dose of VARIVAX (Merck) (Lot# 658572/1257U, therapy dose, route and site unknown). On approximately 08-JUL-2010 the patient experienced break through chicken pox. She had similar lesions a few days after her sister. She was not seen by the doctor. No treatment required. At the time of this report, the patient was doing better. This is one of several reports received from the same source. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of fever in a 70-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included breast cancer. Concomitant products included LYRICA. On 11th June 2018, the patient received the 1st dose of SHINGRIX. In June 2018, several hours after receiving SHINGRIX, the patient experienced fever, upset stomach, heart disorder and headache. On an unknown date, the outcome of the fever, upset stomach, heart disorder and headache were recovered/resolved. The reporter considered the fever, upset stomach, heart disorder and headache to be related to SHINGRIX. Additional details were provided as follows: The patient reported having the SHINGRIX vaccination at noon. The patient started having side effects at midnight that night. The patient was experienced high fever. The patient was unable to get out of bed for 3 days. The patient also felt that her heart didn't give her a full beat like her heart was weak and couldn't complete a full beat. The patient felt that she had these side effects because she only weighs 80 pounds.
Client received immunizations approx 3:00P.M. on 06/18/03. At 4:00P.M. sleepy. Has had elevated temp, lethargy, anorexia ever since with mother giving alternating doses of Tylenol and Motrin. She was taken to Emergency Room on Saturday evening, 6/21. Lab tests performed, Tylenol Supp inserted with temp going from 105.1 to 102.9.  Had had oral Tylenol 2 hrs. previous to suppository. Mother reported no other symptoms. E-Room record reports diarrhea on 6/20. Mother called H.D. on Monday 6/23 with reports of continuing elevated temp, anorexia and lethargy. Mother encouraged to call family physician today. Child sent home on Amoxil 200/5ml,BID. Diagnosis Pharyngitis Child has appointment 2:15, 6-23
Patient complained of dizziness for about 24 hours after vaccination.  There was a red area around vaccination site about 1 to 1.5".
About an hour after injection, started feeling heart race and felt jittery. Arm was sore right away. Next day atm was even more sore and still anxious feeling. Two days later, started having a head ache. Feeling rundown, tired, and bad cough with a sore throat.
I developed burning; itching; blisters under and close to my right eye; shingles infection; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration in Left arm on 27May2021 at 10:30 (at the age of 45 years) as single dose for COVID-19 immunisation. Medical history included fibromyalgia, chronic fatigue syndrome, pcos. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. Concomitant medication included metformin (MANUFACTURER UNKNOWN) and sertraline (MANUFACTURER UNKNOWN) from an unknown date and for unknown indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27May2021 at 15:00, patient experienced burning, itching, blisters under and close to right eye and shingles infection. The patient received any treatment for the reported events, filled anti-viral prescription. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event burning, itching, blisters under and close to right eye and shingles infection were recovering at the time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information regarding their medical history, concurrent conditions nor concomitant therapies provided. On 19-OCT-2021, the patient was vaccinated with an improperly stored dose of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) lot # T042012, expiration date 22-JUL-2023 (exact dose, route of administration and anatomical location were not provided) for prophylaxis (product storage error). The administered vaccine was stored in a temperature of 34.8 degree Fahrenheit (F) for 192 hours. No previous temperature excursion occurred. No adverse effect was reported. This is one of several reports from the same reporter.; Sender's Comments: US-009507513-2112USA000788: US-009507513-2112USA000789: US-009507513-2112USA000790: US-009507513-2112USA000791: US-009507513-2112USA000792.
Around 7pm the evening of receiving my shot, I was extremely tired. When I went to bed around 9 pm, I got chills that lasted at 15 minutes. I finally fell asleep and my husband said I got more chills. I woke up Sunday morning (1-31) and had a fever of 100.5. I took Ib Profen   I was extremely tired and my arm hurt. My appetite has been suppressed since 1-30.  I was also extremely worn out on 2-1. My energy has finally returned.
Patient received 2nd dose at 1226 on 3/19/2021. At approximately 1240, she felt itchiness on her throat both inside and outside. She then took 25mg of Benadryl.  The itchiness didn't subside and she requested another 25mg of Benadryl at 1255. She took a total of 50mg of Benadryl. Her neck was visibly red and she was scratching it. After 5 minutes, she said she felt better. When she left at about 1315, she said she felt nearly 95% normal. She was with her husband, sister and daughter.  She was given instructions to call 911 if her throat felt like it was closing. Compared to her first dose of the vaccine, this was a more mild reaction.
Lancinating pain above right ear and foreheadbeginning 11/13/08.
spot on top of eye; Calf pain; Pain; Hair loss; flare up; COVID-19; Exposure to SARS-CoV-2; This is a solicited report from a marketing program facilitated collect based on information received from a consumer (patient) by Pfizer from AbbVie, manufacturer control number: 21K-163-3824949-00. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via intramuscular in Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous from an unspecified date (Batch/Lot number was not reported) and ongoing, at 40 mg (40 mg,1 in 2-2) for moderate to severe chronic plaque psoriasis psoriatic arthritis. Medical history included ongoing psoriatic arthritis. It was unknown if patient was enrolled in a covid-19 vaccine trial. No known allergies. Concomitant medications included methotrexate; levothyroxine; duloxetine hydrochloride (CYMBALTA); montelukast sodium (SINGULAIR); biotin; and folic acid all taken for an unspecified indication, start and stop date were not reported. On an unknown date, the patient experienced spots on top of eye, flare up, hair loss, aches/pains and calf pain. On 03Mar2021, the patient experienced patient got exposed with covid-19. On 09Mar2021, the patient experienced got sick after getting covid-19 vaccine and had covid-19. Pfizer biontech covid-19 vaccine (tozinameran) was also considered suspect. The patient underwent lab tests and procedures which included covid-19 test: positive on 09Mar2021. The action taken in response to the event for adalimumab was dose not changed. The outcome of Covid-19 was not recovered, outcome of other events was unknown.  Causality for HUMIRA (adalimumab): The reporter's causality for the event of patient got exposed with covid-19 was not provided. The Reporter's causality for the event(s) of spot on top of eye, flare up, got sick after getting covid-19 vaccine and had covid-19, hair loss, aches/pains and calf pain with HUMIRA (adalimumab) was no reasonable possibility. The reporter's assessment of the causal relationship of the events with the suspect vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events spots on top of eye, flare up, hair loss, aches/pains, exposure to covid-19, covid-19 and calf pain cannot be completely excluded based on information provided. However, concomitant adalimumab & underlying psoriatic arthritis were confounders.
Pt received vaccine on 12/18/2003 @ 1600.  Reported to immunization clinic on 12/19/2003 @ 1330 with complained of red, tender, painful, swelling, at immunization site.  Pt seen by flight surgeon.
This spontaneous report was received from a physician referring to 13-month-old patient of unknown gender. No information regarding the patient's pertinent medical history, concomitant medications or drug reactions or allergies was provided. On 07-JUN-2017, the patient was vaccinated with an improperly stored dose of VAQTA (lot # N005274 and expiration date 03-APR-2018; dose and route of administration were not reported) for prophylaxis. It was reported, that on several dates between 25-APR-2017 until 07-SEP-2017, the vaccine was exposed to various temperature excursions ranging from 32 degrees Fahrenheit (F) to 54F for the period of up to 70 hours at a time. Data logger was not involved. No adverse effects were reported. There was no product quality complaint involved. This is one case from several cases from the same reporter.; Sender's Comments:  US-009507513-1709USA012768:
Flu like symptoms, fever 99.9, chills, headache, muscle pain,  no energy, "felt like I was 100yrs old."   Pain to left arm muscle where injection was given
Nine days after vaccination patient developed a vesicular rash and papules that crusted over after opening and experienced intense pruritus.   Patinet's symptoms resolved 23 February 2020.
PATIENT'S ARM BECAME MORE PAINFUL THAT USUAL THE FOLLOWING DAY. PATIENT'S NOSE ALSO BEGAN RUNNING UNCONROLLABLE. THE FOLLOWING NIGHT THE PATIENT LOST BALANCE, MAY HAVE BLACKED OUT AND LAID ON HIS BATHROOM FLOOR FOR A WHILE BEFORE HE COULD REGAIN STRENGTH TO GET BACK UP. STILL FEELING WEAK BUT GRADUALLY FEELING BETTER.
2nd dose greater than 28 days; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose greater than 28 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose greater than 28 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose greater than 28 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Information has been received from a lawyer regarding a case in litigation concerning a female of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 07-JAN-2008, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from his use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to himself, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
It was reported that a 40 year old female patient received Fluzone SV 2001-2002 vaccinated on 10/10/01 at 12 PM. Reportedly within one hour of vaccination the patient developed pruritus and hives that lasted for 48 hours. Treated with Prednisone, Triamunolone cream and Atartar. The patient recovered from this experienced.
Case number PHEH2014US020449, is an initial spontaneous report from a consumer (patient) received on 10 Oct 2014. This report refers to a 70-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with FLUVIRIN (batch number: 14581P) intramuscularly on 07 Oct 2014. On 08 Oct 2014, she developed perspiration, nausea, dizziness and trouble walking. The outcome of the events was unknown. Seriousness and causality was not reported.
Seizure 5/15/06 Medical records received from hospital which reveal patient was admitted overnight 3/10/06-3/11/06 w/possible seizures.  Temp in ER 102.8.  PMH: GERD, bronchiolitis & eczema.
This is a spontaneous report from a non-contactable consumer who reported for oneself. A patient of unspecified age, ethnicity, and gender received pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein), via an unspecified route of administration on an unspecified date at a single dose for an unspecified indication. The patient's medical history and concomitant medications were not reported. It was reported that on an unspecified date, the patient received the pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) at around 5' o clock in the afternoon and at 12 midnight the patient felt like he/she was drugged up. The patient did not throw up but just acid came out of the mouth and the patient felt dizzy. The patient wanted to know if that was any kind of adverse reaction. The patient had not taken any kind of medication not even an acetaminophen (TYLENOL). The outcome of the events was unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria CRM197 protein) has submitted the same report to the regulatory authorities. No follow-up attempts are possible. No further information is expected.
Booster dose was 1ml; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL OVERDOSE (Booster dose was 1ml) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced ACCIDENTAL OVERDOSE (Booster dose was 1ml). In August 2021, ACCIDENTAL OVERDOSE (Booster dose was 1ml) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information were reported.
Gave patient 0.25 Influenza vaccine (should have been 0.5-I called mom and she bought patient back on the same day for additional 0.25 dose.
pt recv vax & inj site became hard & tender w/swelling spreading down to the fingers;also exp fever, malaise & moodiness;
About five hours after the second dose, my eyelids became very itchy. This lasted for an hour or two. During the night, I woke up gasping for air and wheezing. This lasted approximately one hour. The next day I had shortness of breath off and on. I normally have mild seasonal allergies, but four days after vaccination I had the worst allergy attack in years, and it's recurred once or twice a week since then. I still have slight wheezing every day, and I have not been able to resume my regular running due to shallow breathing, which leads to high blood pressure. First dose, left arm: arm soreness, swollen lymph nodes, mild diarrhea
pt was returning to class p/vax & reported afterward that felt faint & cant remember what happened pt was found conscious & responsive;
I have discomforts in my head/I have felt my ears dazed pressure on my head; weak in my legs; my body throbs; I also feel as if I had very strong sinusitis in the T area of my face felt pressure; I started to feel very bad in my head with antumescent pain; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (I have discomforts in my head/I have felt my ears dazed pressure on my head), ASTHENIA (weak in my legs), PAIN (my body throbs), SINUSITIS (I also feel as if I had very strong sinusitis in the T area of my face felt pressure) and HEADACHE (I started to feel very bad in my head with antumescent pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (I have discomforts in my head/I have felt my ears dazed pressure on my head), ASTHENIA (weak in my legs), PAIN (my body throbs), SINUSITIS (I also feel as if I had very strong sinusitis in the T area of my face felt pressure) and HEADACHE (I started to feel very bad in my head with antumescent pain). At the time of the report, HEAD DISCOMFORT (I have discomforts in my head/I have felt my ears dazed pressure on my head), ASTHENIA (weak in my legs), PAIN (my body throbs), SINUSITIS (I also feel as if I had very strong sinusitis in the T area of my face felt pressure) and HEADACHE (I started to feel very bad in my head with antumescent pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Translation Follow up received and does not contain any new information. On 15-Jun-2021: Follow up contain non significant information. On 30-Jul-2021: Translation received and does not contain any new information.
Started with a runny nose - 11th ; body chills (13th-14th) and then a dry cough (14th - 15th) for the rest of the time that I was sick. I was sick through the 22nd or 23rd. No treatment except Tylenol; Advil and Mucinex. On the 31st I went to a doctor - I tested negative but I was still having some digestive issues that had started and some fatigue (physical meltdowns at about 02:00 pm) that started - these started probably right after the coughing stopped. Still have some tightness of breath though. It was a weird cough, I've had asthma my entire life but I have never had a cough like that before. My fatigue started to go away in the last two weeks but I still have the digestive issues. I probably had IBS in high school (early 2000's and late 1990's) but it had gone away all that time and it's just now come back.  Stomach cramping; gas and diarrhea - it's everything I faced in high school and it feels like it has come back.
I had an abscess  close to my rectum.  It became swollen, red, painful to sit, and was full of blood and puss.  I went to the doctors on July 25, or 26th.  It had started to drain heavily .  Dr. was concerned so he sent me to a surgeon on July 28th.   He could not do anything so He sent me to a colon/rectal surgeon.  He actually cut into to let it drain more freely and also did a culture and sent it to the lab.   In the Meantime Dr. put me on antibiotics.  The draining is almost stopped.  It is Aug 5th today.  The whole thing lasted about  3 weeks.
Approximately 5 minutes post injection my blood pressure plummeted and I began to feel faint. I also started shaking uncontrollably particularly hands and arms. Vaccine administrator was immediately notified and they summoned the closest EMT. Emergency Services took my BO and pulse oximeter. A few minutes after the start of the symptoms. They explained that since  my HR was at 84, BP was 110/68 and oxygen saturation was at 98% and I wasn't having difficulty breathing that I was not having an allergic reaction to the vaccine but a parasympathetic response instead. They sat with me until the shaking stopped approximately 15minutes later.
Client came and took additional vaccine after receiving Pfizar on 01/27/2021 and 02/26/2021 another facility
Headache, fever, bone and bodyaches. Inflamed red area at site of injectionwith itching, painful and hot to the touch started within 24 hours after injection. Still red inflamed hot and itchy as of day of report. Fever has resolved, bone and body ache diminished. No betterment as of yet at injection site
This spontaneous report was received from an office manager, referring to a 44 year old female patient. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On 15-JAN-2018, the patient received a dose of GARDASIL 9, intramuscular injection for prophylaxis (drug administered to patient of inappropriate age). The dose, frequency, anatomical location, lot number and expiration date were not reported. The reporter stated that there were no adverse effects reported in the patient.
Sweating, severe dizziness, Chest pain Heart palpitations, Cold/numb arms hands, Hypertension
Came down with a case of Shingles. I am not sure if it would be related but was tole to report on this site by the Vaccine follow up phone call/text.